This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Ultragenyx Pharmaceutical Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Stewart Craig: Innovator in Gene Therapy
Introduction
Stewart Craig is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of gene therapy, holding a total of 3 patents. His work focuses on innovative treatments for rare genetic disorders.
Latest Patents
Among his latest patents are groundbreaking advancements in gene therapy for treating propionic acidemia and gene therapy for treating CDKL5 deficiency disorder. These patents reflect his commitment to developing effective solutions for challenging medical conditions.
Career Highlights
Stewart Craig is currently associated with Ultragenyx Pharmaceutical Inc., a company dedicated to developing innovative therapies for rare diseases. His role at the company allows him to leverage his expertise in gene therapy to make a meaningful impact on patient care.
Collaborations
Stewart has collaborated with notable colleagues, including Matthew Scott Fuller and Sean Christopher Daugherty. These partnerships enhance the research and development efforts within the field of gene therapy.
Conclusion
Stewart Craig's contributions to gene therapy exemplify his dedication to advancing medical science and improving the lives of patients with rare genetic disorders. His innovative work continues to inspire future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile